GSK plc (LON:GSK)
London · Delayed Price · Currency is GBP · Price in GBX 1,479.50
-13.00 (-0.87%)
Aug 22, 2025, 7:14 PM BST
GSK plc Market Cap
GSK plc has a market cap or net worth of 60.14 billion as of August 22, 2025. Its market cap has decreased by -5.82% in one year.
Market Cap
60.14B
Enterprise Value
73.44B
Revenue
31.63B
Ranking
n/a
PE Ratio
18.06
Stock Price
1,479.50
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has decreased from 64.68B to 60.14B, a decrease of -7.02%. That is a compound annual growth rate of -0.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 60.14B | 9.46% |
| Dec 31, 2024 | 54.94B | -7.05% |
| Dec 29, 2023 | 59.11B | 1.25% |
| Dec 30, 2022 | 58.38B | -27.44% |
| Dec 31, 2021 | 80.46B | 20.44% |
| Dec 31, 2020 | 66.80B | -24.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 186.83B |
| Haleon | 32.80B |
| Smith & Nephew | 12.08B |
| ConvaTec Group | 4.96B |
| Hikma Pharmaceuticals | 4.03B |
| HUTCHMED (China) | 2.04B |
| Oxford Nanopore Technologies | 2.03B |
| Genus | 1.78B |